Sun Pharmaceutical Industries has scheduled January 31 as the date for announcing its financial performance for the quarter ending December 2021 (Q3FY22).
The Company will conduct an hour-long call at 06.30 pm IST on January 31, 2022, where senior management will discuss the Company’s performance and answer questions from participants.
On Wednesday, the company’s stock was under pressure. At around 10.49 am, Sun Pharma was performing at Rs836.80 per piece down by 1.08%.
The stock has touched an intraday high and low of Rs846.15 per piece and Rs834.05 per piece respectively.
In the September 2021 quarter (Q2FY22), Sun Pharma reported a 12.54% yoy rise in total revenues on a consolidated basis at Rs9,626cr. The consolidated Profit after tax (PAT) was up by 12.92% yoy at Rs2,047cr as most of the operating cost items including the raw material costs remained stable during the quarter.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.